Investor Overview

VYNE Therapeutics® is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

1.00

May. 21, 2025 16:00:00
  • Change -0.15 (-13.04348%)
  • Volume 747,664
  • Today's Open 1.15
  • Previous Close 1.15
  • Today's High 1.15
  • Today's Low 0.9962
  • 52 Week High 4.3
  • 52 Week Low 0.998